A 212-kb Region on Chromosome 6q25 Containing the TAB2 Gene Is Associated With Susceptibility to Type 1 Diabetes
- From the Molecular Diabetes and Metabolism Section and the Harry B. and Aileen B. Gordon Diabetes Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Address correspondence and reprint requests to Dr. David Owerbach, Department of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. E-mail: davido{at}bcm.tmc.edu
Abstract
The IDDM5 gene, which is identified by whole-genome searches, is located on chromosome 6q25. TAB2 (MAP3K7IP2 [mitogen-activating protein kinase kinase kinase 7 interacting protein 2]) is a potential candidate gene for type 1 diabetes because it is located on chromosome 6q25 and is involved in nuclear factor (NF)-κB regulation. We have conducted familial association studies using 478 families and demonstrate that a type 1 diabetes susceptibility gene resides within a 212-kb region containing the TAB2 gene (Tsp = 1.0 × 10−2 to 4.0 × 10−4). No amino acid polymorphisms were detected in TAB2; however, multiple single nucleotide polymorphisms (SNPs) found within 5′ untranslated, 3′ untranslated, and intron regions were associated with type 1 diabetes susceptibility. Two additional genes, LOC340152, a predicted gene with currently unknown function, and SMT3, which has homology to SUMO (small ubiquitin-related modifier) were found within the 212-kb region and were associated with type 1 diabetes susceptibility. Functional studies of the three genes will be required to determine their biological relevance to type 1 diabetes. However, both TAB2 and SUMO are involved in NF-κB activation and may thus be involved in type 1 diabetes through apoptosis in pancreatic β-cells.
- LD, linkage disequilibrium
- NF, nuclear factor
- SBE, single base extension
- SNP, single nucleotide polymorphism
- SUMO, small ubiquitin-related modifier
- TAB2, mitogen-activating protein kinase kinase kinase 7 interacting protein 2
- TDT, transmission disequilibrium test
Footnotes
-
- Accepted March 30, 2004.
- Received February 10, 2003.
- DIABETES














